Showing results 1 to 12 of 12
| Title | Author(s) | Issue Date | Views | |
|---|---|---|---|---|
Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents Journal:Signal Transduction and Targeted Therapy | 1-Dec-2022 | |||
| 2006 | 107 | |||
Double EGFR mutants containing rare EGFR mutant types show reduced in vitro response to gefitinib compared with common activating missense mutations Journal:Molecular Cancer Therapeutics | 2009 | |||
EGFR mutations are prevalent and independent from K-RAS mutations in lung adenocarcinomas from non-smokers Proceeding/Conference:Research Postgraduate Symposium, RPS 2004 | 2004 | 92 | ||
EGFR mutations are prevalent and independent from K-RAS mutations in lung adenocarcinomas from non-smokers Proceeding/Conference:Cancer Research | 2005 | |||
| 2009 | 176 | |||
| 2005 | ||||
| 1-Mar-2023 | ||||
| 2006 | ||||
| 2005 | 136 | |||
Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunity Journal:Frontiers in Immunology | 20-Sep-2022 | |||
| 2009 |